A citation-based method for searching scientific literature

Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding, Marc S Sabatine. Lancet 2019
Times Cited: 882



Søren L Kristensen, Rasmus Rørth, Pardeep S Jhund, Kieran F Docherty, Naveed Sattar, David Preiss, Lars Køber, Mark C Petrie, John J V McMurray. Lancet Diabetes Endocrinol 2019
Times Cited: 294




List of shared articles



Times cited

Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking program.
Taufiq Salahuddin, Vanessa Richardson, Demetria M McNeal, Kamal Henderson, Paul L Hess, Sridharan Raghavan, David R Saxon, Javier A Valle, Stephen W Waldo, P Michael Ho,[...]. Diabetes Obes Metab 2021
0






Practical Considerations and Rationale for Glucagon-Like Peptide-1 Receptor Agonist Plus Sodium-Dependent Glucose Cotransporter-2 Inhibitor Combination Therapy in Type 2 Diabetes.
Ronald M Goldenberg, Vineeta Ahooja, Kristin K Clemens, Jeremy D Gilbert, Megha Poddar, Subodh Verma. Can J Diabetes 2021
1

Nephropathy in Diabetes.
Ludwig Merker, Bernd-Walter Bautsch, Thomas Ebert, Martina Guthoff, Berend Isermann. Exp Clin Endocrinol Diabetes 2021
0

Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes.
Ambarish Pandey, Muthiah Vaduganathan, Kershaw V Patel, Colby Ayers, Christie M Ballantyne, Mikhail N Kosiborod, Mercedes Carnethon, Christopher DeFilippi, Darren K McGuire, Sadiya S Khan,[...]. JACC Heart Fail 2021
3

Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic Perspectives.
Alessandro Bellis, Ciro Mauro, Emanuele Barbato, Antonio Ceriello, Antonio Cittadini, Carmine Morisco. Int J Mol Sci 2021
2

Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis.
Santo Colosimo, Federico Ravaioli, Maria L Petroni, Lucia Brodosi, Francesca Marchignoli, Francesca A Barbanti, Anna S Sasdelli, Giulio Marchesini, Loris Pironi. Liver Int 2021
1

Treatments for NAFLD: State of Art.
Alessandro Mantovani, Andrea Dalbeni. Int J Mol Sci 2021
3

Guideline Adherence and Associated Outcomes in the Treatment of Type 2 Diabetes Mellitus Patients With an Incident Cardiovascular Comorbidity: An Analysis Based on a Large German Claims Dataset.
Maximilian Gabler, Nils Picker, Silke Geier, Ludwin Ley, Jens Aberle, Michael Lehrke, Stephan Martin, Matthias Riedl, Thomas Wilke. Diabetes Ther 2021
0

Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.
Matthew W Segar, Kershaw V Patel, Muthiah Vaduganathan, Melissa C Caughey, Byron C Jaeger, Mujeeb Basit, Duwayne Willett, Javed Butler, Partho P Sengupta, Thomas J Wang,[...]. Diabetologia 2021
0

Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study.
Moa Lugner, Naveed Sattar, Mervete Miftaraj, Jan Ekelund, Stefan Franzén, Ann-Marie Svensson, Björn Eliasson. Cardiovasc Diabetol 2021
1